← Leaderboards
Robert L Jilka
University Of Arkansas Med Scis Ltl Rock
$4,255,374
Attributed
$4,255,374
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $290.6K · FY2006–16$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$4,255,374 · 5
VA$0 · 1
By mechanism
P01$2,967,699 · 4
R01$1,287,675 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Arkansas Med Scis Ltl Rock
Same institution · by research overlap
- Stavros C. Manolagas$5,168,384
- Beata Anna Lecka-Czernik$4,344,808
- Teresita M Bellido$8,482,287
- Robert Jika$0
- Robert Stewart Weinstein$5,747,652
Others in their field
Top investigators on “Osteogenesis”
- Brendan Hl Lee · Baylor College Of Medicine$22,361,547
- Jake Jinkun Chen · Tufts University Boston$15,367,439
- Gerard Karsenty · University Of Texas Md Anderson Can Ctr$14,769,220
- Roland E Baron · Massachusetts General Hospital$14,764,645
- Sundeep Khosla · Mayo Clinic Rochester$14,620,741
- Fanxin Long · Children'S Hosp Of Philadelphia$13,434,578
Research focus
OsteogenesisOsteoblastsApoptosisFundingResponseBaseMediatingFractureProgenitorOsteoporosisBone LossParathyroid HormonesHormonesBone MassBoneOverexpressionElderlyEnzymesDba/2 MouseAge RelatedExhibitsLipid BiosynthesisAntioxidantsC57bl/6 Mouse
Grant awards (21)
OXIDIZED LIPIDS, BONE LOSS AND ITS REVERSAL BY INTERMITTENT PTH$290,613
P01 · FY2016 · AG · contact PI
OXIDIZED LIPIDS, BONE LOSS AND ITS REVERSAL BY INTERMITTENT PTH$281,894
P01 · FY2015 · AG · contact PI
OXIDIZED LIPIDS, BONE LOSS AND ITS REVERSAL BY INTERMITTENT PTH$290,613
P01 · FY2014 · AG · contact PI
OXIDIZED LIPIDS, BONE LOSS AND ITS REVERSAL BY INTERMITTENT PTH$274,628
P01 · FY2013 · AG · contact PI
Regulation of osteoblast number by PTH$0
I01 · FY2013 · VA · contact PI
OXIDIZED LIPIDS, BONE LOSS AND ITS REVERSAL BY INTERMITTENT PTH$290,449
P01 · FY2012 · AG · contact PI
Regulation of osteoblast number by PTH$0
I01 · FY2012 · VA · contact PI
Regulation of osteoblast number by PTH$0
I01 · FY2012 · VA · contact PI
Regulation of osteoblast number by PTH$0
I01 · FY2011 · VA · contact PI
OXIDIZED LIPIDS, AGE-RELATED BONE LOSS AND ITS REVERSAL BY INTERMITTENT PTH$261,797
P01 · FY2010 · AG · contact PI
OXIDIZED LIPIDS, AGE-RELATED BONE LOSS AND ITS REVERSAL BY INTERMITTENT PTH$256,812
P01 · FY2009 · AG · contact PI
OXIDIZED LIPIDS, AGE-RELATED BONE LOSS AND ITS REVERSAL BY INTERMITTENT PTH$252,664
P01 · FY2008 · AG · contact PI
OXIDIZED LIPIDS, AGE-RELATED BONE LOSS AND ITS REVERSAL BY INTERMITTENT PTH$220,331
P01 · FY2007 · AG · contact PI
OXIDIZED LIPIDS, AGE-RELATED BONE LOSS AND ITS REVERSAL BY INTERMITTENT PTH$155,144
P01 · FY2006 · AG · contact PI
PTH STIMULATED BONE FORMATION$247,835
R01 · FY2004 · AR
PTH STIMULATED BONE FORMATION$247,835
R01 · FY2003 · AR
PTH STIMULATED BONE FORMATION$247,835
R01 · FY2002 · AR
PTH STIMULATED BONE FORMATION$247,835
R01 · FY2001 · AR
PTH STIMULATED BONE FORMATION$296,335
R01 · FY2000 · AR
CORE--ANIMAL$196,377
P01 · FY2000 · AG
BIRTH AND DEATH OF OSTEOBLASTS--DETERMINANTS OF BONE MASS$196,377
P01 · FY2000 · AG